Please Wait
Applying Filters...
menu
    • menu
    CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Inebilizumab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    31/10/2025 AstraZeneca
    United Kingdom
    		 AstraZeneca Pharmaceuticals LP 303MF40004 Culture medium/culture medium additives・Inebelizumab ... 2021-01-26 2021-01-26 One MedImmune Way, Gaithersburg, MD 20878, USA
    31/10/2025 AstraZeneca
    United Kingdom
    		 AstraZeneca Pharmaceuticals LP 303MF40003 Culture medium/culture medium additives・Inebilizumab ... 2021-01-26 2021-01-26 One MedImmune Way, Gaithersburg, MD 20878, USA